Xylem (XYL) Research & Development (2010 - 2026)

Xylem's Research & Development history runs 17 years deep, the most recent figure standing at $56.0 million for Q1 2026.

• On a quarterly basis, Research & Development changed 0.0% year-over-year to $56.0 million in Q1 2026; TTM through Mar 2026 was $226.0 million, a 0.44% change from a year earlier, with the FY2025 full-year figure at $226.0 million, down 1.74% from the prior year.
• Research & Development fell to $56.0 million in Q1 2026 per XYL's latest filing, from $60.0 million in the prior quarter.
• Across five years, Research & Development topped out at $61.0 million in Q3 2023 and bottomed at $47.0 million in Q3 2022.
• The 5-year median for Research & Development is $56.0 million (2025), against an average of $55.9 million.
• Across the five-year window, Research & Development advanced 29.79% in 2023 and declined 9.84% in 2024, its largest moves.
• Year by year, Research & Development stood at $54.0 million in 2022, then gained by 11.11% to $60.0 million in 2023, then retreated by 3.33% to $58.0 million in 2024, then increased by 3.45% to $60.0 million in 2025, then dropped by 6.67% to $56.0 million in 2026.
• Per Business Quant, the three latest XYL Research & Development figures stand at $56.0 million (Q1 2026), $60.0 million (Q4 2025), and $52.0 million (Q3 2025).